147 related articles for article (PubMed ID: 35383431)
21. Two cycles of neoadjuvant chemotherapy improves survival in patients with high-risk upper tract urothelial carcinoma.
Zennami K; Sumitomo M; Takahara K; Nukaya T; Takenaka M; Fukaya K; Ichino M; Fukami N; Sasaki H; Kusaka M; Shiroki R
BJU Int; 2021 Mar; 127(3):332-339. PubMed ID: 32896105
[TBL] [Abstract][Full Text] [Related]
22. National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapy.
Rodrigues Pessoa R; Morrison JC; Konety B; Gershman B; Maroni P; Kukreja JB; Cost N; Flaig T; Kessler E; Sharma P; Kim SP
Urol Oncol; 2021 Dec; 39(12):832.e9-832.e15. PubMed ID: 33820697
[TBL] [Abstract][Full Text] [Related]
23. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
[TBL] [Abstract][Full Text] [Related]
24. Effects of Adjuvant Chemotherapy on Locally Advanced Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis.
Kim DK; Kim JW; Jung HD; Ahn HK; Lee JY; Cho KS
Clin Genitourin Cancer; 2019 Dec; 17(6):e1193-e1202. PubMed ID: 31543442
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage.
Baboudjian M; Al-Balushi K; Michel F; Lannes F; Akiki A; Gaillet S; Delaporte V; Ragni E; Toledano H; Karsenty G; Rossi D; Bastide C; Lechevallier E; Boissier R
World J Urol; 2020 Jan; 38(1):159-165. PubMed ID: 30993427
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant chemotherapy for upper tract urothelial carcinoma.
Kim DK; Cho KS
Transl Cancer Res; 2020 Oct; 9(10):6576-6582. PubMed ID: 35117267
[TBL] [Abstract][Full Text] [Related]
27. The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis.
Stangl-Kremser J; Muto G; Grosso AA; Briganti A; Comperat E; Di Maida F; Montironi R; Remzi M; Pradere B; Soria F; Albisinni S; Roupret M; Shariat SF; Minervini A; Teoh JY; Moschini M; Cimadamore A; Mari A;
Urol Oncol; 2022 Jun; 40(6):243-261. PubMed ID: 35241364
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant Chemotherapy in Elderly Patients With Upper Tract Urothelial Cancer: Oncologic Outcomes From a Multicenter Study.
Grossmann NC; Pradere B; D'Andrea D; Schuettfort VM; Mori K; Rajwa P; Quhal F; Laukhtina E; Katayama S; Fankhauser CD; Xylinas E; Margulis V; Moschini M; Abufaraj M; Bandini M; Lonati C; Nyirady P; Karakiewicz PI; Fajkovic H; Shariat SF
Clin Genitourin Cancer; 2022 Jun; 20(3):227-236. PubMed ID: 35125303
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma.
Porten S; Siefker-Radtke AO; Xiao L; Margulis V; Kamat AM; Wood CG; Jonasch E; Dinney CP; Matin SF
Cancer; 2014 Jun; 120(12):1794-9. PubMed ID: 24633966
[TBL] [Abstract][Full Text] [Related]
30. Impact of Neoadjuvant Chemotherapy on Pathologic Response in Patients With Upper Tract Urothelial Carcinoma Undergoing Extirpative Surgery.
Almassi N; Gao T; Lee B; Stein RJ; Haber GP; Ornstein MC; Rini BI; Gilligan TD; Garcia JA; Stephenson AJ; Grivas P
Clin Genitourin Cancer; 2018 Dec; 16(6):e1237-e1242. PubMed ID: 30217764
[TBL] [Abstract][Full Text] [Related]
31. Overview, Diagnosis, and Perioperative Systemic Therapy of Upper Tract Urothelial Carcinoma.
Kolawa A; D'Souza A; Tulpule V
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835507
[TBL] [Abstract][Full Text] [Related]
32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
33. Catalog of prognostic tissue-based biomarkers in patients treated with neoadjuvant systemic therapy for urothelial carcinoma of the bladder: a systematic review.
Laukhtina E; Pradere B; Mori K; Schuettfort VM; Quhal F; Mostafaei H; Sari Motlangh R; Katayama S; Grossmann NC; Moschini M; Enikeev D; Shariat SF;
Urol Oncol; 2021 Mar; 39(3):180-190. PubMed ID: 33423937
[TBL] [Abstract][Full Text] [Related]
34. Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma.
Adibi M; McCormick B; Economides MP; Petros F; Xiao L; Guo C; Shah A; Kamat AM; Dinney C; Navai N; Gao J; Siefker-Radtke A; Matin SF; Campbell MT
Clin Genitourin Cancer; 2022 Apr; 20(2):176-182. PubMed ID: 35039231
[TBL] [Abstract][Full Text] [Related]
35. Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer.
Roscigno M; Brausi M; Heidenreich A; Lotan Y; Margulis V; Shariat SF; Van Poppel H; Zigeuner R
Eur Urol; 2011 Oct; 60(4):776-83. PubMed ID: 21798659
[TBL] [Abstract][Full Text] [Related]
36. Oncological outcomes of laparoscopic versus open nephroureterectomy for the treatment of upper tract urothelial carcinoma: an updated meta-analysis.
Piszczek R; Nowak Ł; Krajewski W; Chorbińska J; Poletajew S; Moschini M; Kaliszewski K; Zdrojowy R
World J Surg Oncol; 2021 Apr; 19(1):129. PubMed ID: 33882936
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of renal function for upper tract urothelial carcinoma who underwent radical nephroureterectomy: Sex differences.
Chien TM; Li CC; Lu YM; Chang HW; Chou YH; Wu WJ
J Formos Med Assoc; 2022 Nov; 121(11):2182-2190. PubMed ID: 35370029
[TBL] [Abstract][Full Text] [Related]
38. A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02.
Necchi A; Martini A; Raggi D; Cucchiara V; Colecchia M; Lucianò R; Villa L; Mazzone E; Basile G; Scuderi S; Pederzoli F; Bandini M; Barletta F; Larcher A; Capitanio U; Salonia A; Briganti A; Ross JS; Messina A; Montorsi F
Urol Oncol; 2022 Jan; 40(1):10.e1-10.e6. PubMed ID: 34147313
[TBL] [Abstract][Full Text] [Related]
39. Upper urinary tract recurrence following bladder cancer therapy: a review of surveillance and management.
Naser-Tavakolian A; Ghodoussipour S; Djaladat H
Curr Opin Urol; 2019 May; 29(3):189-197. PubMed ID: 30762673
[TBL] [Abstract][Full Text] [Related]
40. Survival Outcomes in Neoadjuvant Chemotherapy for High-grade Upper Tract Urothelial Carcinoma: A Nationally Representative Analysis.
Khan AI; Taylor BL; Al Hussein Al Awamlh B; Posada Calderon L; Fainberg J; Elahjji R; Shoag J; Scherr DS
Urology; 2020 Dec; 146():158-167. PubMed ID: 32896584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
